NRUC - NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/


24.8
-0.370   -1.492%

Share volume: 94,360
Last Updated: 08-30-2024

PREVIOUS CLOSE
CHG
CHG%

$25.17
-0.37
-1.47%
This ticker is disabled and data are no longer maintained and up to date.
Company vs Stock growth
vs
Performance
5 Days
-1.48%
1 Month
-5.10%
3 Months
-7.59%
6 Months
-5.29%
1 Year
-6.96%
2 Year
-3.45%
Key data
Stock price
$24.80
P/E Ratio 
0.00
DAY RANGE
$24.61 - $25.11
EPS 
$0.00
52 WEEK RANGE
$22.92 - $25.70
52 WEEK CHANGE
-$6.89
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
$0.3438
EX-DIVIDEND DATE
08-01-2024
NEXT EARNINGS DATE
N/A
BETA 
0.30
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$151,806
AVERAGE 30 VOLUME 
$65,169
Company detail
CEO: J. Andrew Don
Region: US
Website: www.nephrogenex.com
Employees: 1,700
IPO year: 2019
Issue type:
Market: NYSE
Industry:
Sector:

NephroGenex, Inc. is a pharmaceutical company, which focuses on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. It is developing Pyridorin, a small molecule drug that is acting inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients. The company was founded by Billy G. Hudson, J. Wesley Fox Ahmann and Tryggvason Karl on May 25, 2004 and is headquartered in Raleigh, NC.

Recent news